Nonclinical Mouse PK/PD Study Execution
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract requires the execution of in vivo pharmacokinetic and pharmacodynamic studies in mice to evaluate novel NNMT inhibitors, encompassing all aspects of animal dosing, blood and tissue sample collection, and proper handling of biological specimens to ensure data integrity. The work must adhere to standardized protocols for assessing drug absorption, distribution, metabolism, and excretion alongside downstream biomarker analysis to determine pharmacodynamic effects in live animal models. This subcontract is issued under the NAICS code 541620, indicating it pertains to scientific research and development services, and is solicited by the National Institutes of Health through the Department of Health and Human Services. The opportunity was posted on August 8, 2026, with a response deadline of August 24, 2026, and performance is expected to be conducted under the oversight of the NIH without specified geographic limitations. The scope demands expertise in preclinical mouse studies, robust sample processing, and precise pharmacological data generation to support further drug development decisions.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
